Ultivent-MTM Cozycap

Indacaterol + Glycopyrronium + Mometasone Furoate
Beta-2 Agonist + Anticholinergic + Corticosteroid (Antiasthma)

Indication:
It is once-daily triple combination for the patients with moderate to severe asthma who treated earlier with an ICS/LABA dual combination.

Dosage & Administration:
1 Cozycap once daily by oral inhalation through revolizerTM device.

Preparation:
Ultivent-MTM Cozycap: Each box contains 10 Cozycaps in Alu-Alu blister.

  • Ultivent-M<sup>TM</sup> Cozycap

  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides